Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis B, Chronic”

1,199 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,199 results

Testing effectiveness (Phase 2)Ended earlyNCT01425970
What this trial is testing

Chronically-infected HCV Genotype 2 and 3 Treatment-naive Subjects: Part A: Safety and Efficacy of INX-08189 With Peg IFN Alfa-2a and Ribavirin. Part B: INX-08189 in Interferon Free Treatment With Daclatasvir and/or Ribavirin

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 210
Not applicableUnknownNCT05991531
What this trial is testing

Dynamic Changes of Serum HBV RNA in Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis B Patients
Beijing Friendship Hospital 100
Large-scale testing (Phase 3)Study completedNCT00410202
What this trial is testing

Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant Virus

Who this might be right for
Hepatitis B, Chronic
Bristol-Myers Squibb 629
Large-scale testing (Phase 3)Active Not RecruitingNCT03489239
What this trial is testing

Entecavir to TAF Switch

Who this might be right for
Hepatitis B
Thomas Jefferson University 27
Not applicableStudy completedNCT02689245
What this trial is testing

Randomized Controlled Trial Comparing the Efficacy and Safety of FMT in Hepatitis B Reactivation Leads to Acute on Chronic Liver Failure.

Who this might be right for
Acute on Chronic Liver Failure
Institute of Liver and Biliary Sciences, India 64
Post-approval studies (Phase 4)Not Yet RecruitingNCT06900166
What this trial is testing

Pegylated Interferon Alfa-2b in Reducing Relapse Rates After Nucleos(t)ide Analogue Withdrawal in HBeAg-negative CHB Patients with Low Level HBsAg

Who this might be right for
Chronic Hepatitis B
Huashan Hospital 360
Large-scale testing (Phase 3)Study completedNCT00115245
What this trial is testing

Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Novartis
Testing effectiveness (Phase 2)Looking for participantsNCT05771402
What this trial is testing

A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (B)

Who this might be right for
Chronic Hepatitis bAnti-PD-1 AntibodyPeg-IFNα
The Second Affiliated Hospital of Chongqing Medical University 120
Large-scale testing (Phase 3)Study completedNCT00536263
What this trial is testing

PegIntron Treatment of Chronic Hepatitis B e Antigen-Positive Patients (P05170/MK-4031-327)

Who this might be right for
Hepatitis B, Chronic
Merck Sharp & Dohme LLC 671
Not applicableNot Yet RecruitingNCT07727187
What this trial is testing

Hepatitis B Infection Surveillance

Who this might be right for
Chronic Hepatitis B Infection
Assistance Publique - Hôpitaux de Paris 1,360
Large-scale testing (Phase 3)Study completedNCT02613871
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Adults With Chronic HCV and HBV Coinfection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 111
Post-approval studies (Phase 4)WithdrawnNCT00782301
What this trial is testing

Maraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected Patients

Who this might be right for
Hepatitis BHuman Immunodeficiency VirusHepatitis C, Chronic
ViiV Healthcare
Large-scale testing (Phase 3)Study completedNCT01369212
What this trial is testing

Combination Therapy of Pegylated Interferon Alfa-2a and Tenofovir Versus Tenofovir Monotherapy in Chronic Hepatitis B

Who this might be right for
Hepatitis B
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 201
Post-approval studies (Phase 4)UnknownNCT02482272
What this trial is testing

Compare Continuing Lamivudine Plus Adefovir or Adefovir Versus Switching to Entecavir Plus Adefovir in Patients With LAM-resistant Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Asan Medical Center 90
Not applicableStudy completedNCT05871749
What this trial is testing

Effects of Hepatic Fibrosis on Hepatic Steatosis Using the Ultrasound Attenuation Imaging in Chronic Hepatitis B

Who this might be right for
Hepatic SteatosisHepatic FibrosisChronic Hepatitis b
So Yeon Kim 120
Post-approval studies (Phase 4)UnknownNCT04070079
What this trial is testing

Tenofovir Alafenamide With Fine Needle Aspiration Biopsy in Chronic Hepatitis B:

Who this might be right for
Hepatitis B, Chronic
University Health Network, Toronto 15
Testing effectiveness (Phase 2)Looking for participantsNCT07630727
What this trial is testing

Study of AHB-171 in Chronic Hepatitis B Participants

Who this might be right for
Hepatitis B, Chronic (CHB)
Ausper Biopharma Co., Ltd. 138
Not applicableUnknownNCT02167503
What this trial is testing

Observational Study on Patients With Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Nanfang Hospital, Southern Medical University 10,000
Not applicableStudy completedNCT01282762
What this trial is testing

Long-Term Study on Safety and Immunogenicity of HEPLISAV™ and Engerix-B® in Adults With Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease
Dynavax Technologies Corporation 147
Testing effectiveness (Phase 2)Study completedNCT00363155
What this trial is testing

KRN7000 in Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Foundation for Liver Research 28
Next Page